Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease

Published:2017-09 Issue:9 Volume:23 Page:1478-1484
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Yalniz Fevzi F.,Hefazi Mehrdad,McCullough Kristen,Litzow Mark R.,Hogan William J.,Wolf Robert,Alkhateeb Hassan,Kansagra Ankit,Damlaj Moussab,Patnaik Mrinal M.

Funder

Mayo Clinic

National Center for Advancing Translational Science

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference42 articles.

1. Diagnosis and management of acute graft-versus-host disease;Dignan;Br J Haematol,2012

2. Steroid-refractory acute GVHD: predictors and outcomes;Westin;Adv Hematol,2011

3. A phase III randomized trial comparing Inolimomab vs. usual care in steroid-resistant acute GVHD;Socie;Blood,2017

4. Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation;Martin;Bone Marrow Transplant,2014

5. Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin;Van Lint;Blood,2006

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation;Current Research in Translational Medicine;2024-09

2. Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease;Frontiers in Immunology;2024-07-03

3. Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study;Cancers;2023-07-13

4. Diagnostic, prophylaxie et prise en charge thérapeutique de la GVH aiguë : recommandations de la SFGM-TC;Bulletin du Cancer;2023-02

5. Steroid-Sensitive, but Not Steroid-Dependent or Steroid-Resistant Acute Graft-versus-Host Disease, Results in Similar Infection Risk as No Graft-versus-Host Disease following Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2022-08